Janel (JANL) ROCE % : 10.48% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Janel ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Janel's annualized ROCE % for the quarter that ended in Dec. 2023 was 10.48%.

Janel ROCE % Historical Data

The historical data trend for Janel's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Janel ROCE % Chart

Janel Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROCE %

Get a 7-Day Free Trial

7.09

-6.84

22.02

3.41

6.35

Janel Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															9.47	7.83	-0.83	8.60	10.48

Janel ROCE % Calculation

Janel's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	2.523	/	( ( (126.532 - 85.036)	+	(96.834 - 58.837) )	/ 2 )
	=	2.523	/	( (41.496	+	37.997)	/ 2 )
	=	2.523	/	39.7465
	=	6.35 %

Janel's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	3.968	/	( ( (96.834 - 58.837)	+	(91.502 - 53.802) )	/ 2 )
	=	3.968	/	( ( 37.997	+	37.7 )	/ 2 )
	=	3.968	/	37.8485
	=	10.48 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Janel (OTCPK:JANL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Janel ROCE % Related Terms

Thank you for viewing the detailed overview of Janel's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Janel (JANL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Janel Corp (OTCPK:JANL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

80 Eighth Avenue, New York, NY, USA, 10011

Website

https://www.janelcorp.com

Janel Corp is a holding company. The company's operating segments include Logistics Services, Manufacturing, and Life Sciences. The logistics Services segment is a full-service provider of cargo transportation logistics management services, including freight forwarding via air, ocean, and land-based carriers, customs brokerage services, warehousing, and distribution services. The Manufacturing segment is engaged in manufacturing and distributing industrial mixing equipment and apparatus for specific applications within various industries. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research. It generates maximum revenue from the Logistics Services segment.

Executives

Kesteren Gerard Van	director	80 EIGHTH AVENUE, NEW YORK NY 10011
Gregory B Graves	director	129 CONCORD ROAD, BILLERICA MA 01821
Dominique Schulte	10 percent owner	68 BANK STREET, NEW YORK NY 10014
Brendan James Killackey	director	80 EIGHTH AVENUE, NEW YORK NY 10011
Oaxaca Group L.l.c.	10 percent owner	68 BANK STREET, NEW YORK NY 10014
Vincent Verde	officer: CFO	C/O JANEL CORPORATION, 303 MERRICK ROAD, SUITE 400, LYNBROOK NY 11563
Ryan Karen Miller	director	2260 S ADAMS, DENVER CO 80210
John Eidinger	10 percent owner	80 EIGHTH AVENUE, NEW YORK NY 10011
Gonzalez John Joseph Ii	10 percent owner, officer: SR Managing Director NE Region	7 PARSONS LANDING, ISLIP NY 11751
Gregory J Melsen	director	614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
James N Jannello	10 percent owner	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563
Carlos Pla	officer: CFO	303 MERRICK ROAD, SUITE 400, LYNBROOK NY 11563
Brian Aronson	officer: CFO	745 BOULEVARD EAST, WEEHAWKEN NJ 07086
Nicholas V Ferrara	director	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563
Philip J Dubato	officer: EVP of Finance	303 MERRICK ROAD - SUITE 200, LYNBROOK NY 11563

Janel (JANL) Headlines

From GuruFocus

Director Kesteren Van Acquires 3,000 Shares of Janel Corp (JANL)

By GuruFocus Research • 02-29-2024